Anthony Gentile
Corporate Officer/Principal chez BIOHAVEN PHARMACEUTICAL HOLDING COMPANY LTD.
Profil
M. Anthony Gentile est directeur des opérations cliniques et du programme financier chez Biohaven Pharmaceutical Holding Co. Ltd.
Postes actifs de Anthony Gentile
| Sociétés | Poste | Début |
|---|---|---|
| BIOHAVEN PHARMACEUTICAL HOLDING COMPANY LTD. | Corporate Officer/Principal | 01/02/2014 |
Formation de Anthony Gentile
| Eastern Connecticut State University | Undergraduate Degree |
| University of Hartford | Graduate Degree |
| Rensselaer Polytechnic Institute | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 1 |
|---|---|
Biohaven Pharmaceutical Holding Co. Ltd.
 Biohaven Pharmaceutical Holding Co. Ltd. Pharmaceuticals: MajorHealth Technology Biohaven Pharmaceutical Holding Co. Ltd. is a clinical-stage biopharmaceutical company, which engages in the research and development of late-stage product candidates targeting neurological diseases, including rare disorders. It focuses on a pipeline of product candidates that represent mechanistic platforms, calcitonin gene-related peptide receptor antagonists, and glutamate modulators. The company was founded in September 2013 and is headquartered in New Haven, CT. | Health Technology |